TCL Archive How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval September 30, 2011
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says November 29, 1996
TCL Archive Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future March 1, 1996
